BETHESDA, Md., Thurs., Sept. 7, 2006 – The National Institutes of Health (NIH) today awarded a set of cooperative agreements, totaling up to $52 million over five years, to launch the Knockout Mouse ...

In recent debate over the FDA's approval of the Alzheimer's drug aducanumab, we've heard a lot about the "amyloid hypothesis." In that context, it's refreshing to learn about a model of Alzheimer's ...

Super immunodeficient mouse models with knockout of murine Fc gamma receptors (FcγRs) have emerged as valuable tools in biomedical research for improving the accuracy of preclinical experimental ...

GluN3A-deficient mice display all aspects of Alzheimer's neurodegeneration. In the context of recent debate over the FDA's approval of aducanumab, it's refreshing to learn about a model of Alzheimer's ...